Gaithersburg-based financial services & venture capital fund for early stage investments.
50
Operating
Gaithersburg, MD, US
Novel Bioventures is an early-stage venture capital fund based in Gaithersburg, Maryland. The firm focuses on investing in biotechnology and healthcare companies, typically participating in Series B funding rounds. While specific investment sizes are not disclosed, their portfolio suggests a preference for substantial commitments to promising ventures.
Notable portfolio companies include Cellerant Therapeutics and TransMedics, with the latter having raised over $27 million. Novel Bioventures' investment strategy appears to target innovative companies in the life sciences sector, supporting their growth through crucial development stages. The firm's Gaithersburg location positions it well to access biotechnology hubs along the East Coast.
Portfolio Snapshot
Portfolio activity breakdown across disclosed investments and stages
Portfolio Companies2
Current Portfolio Count2
Top Investment Stages
Series B2 (100.0%)
Stage Mix
Series B 100%
Concentration shown as share of disclosed investments by stage.
